Gigabases Switzerland AG

Gigabases is a synthetic biology company that combines artificial intelligence and digital technology to help researchers design proteins and order expression plasmids. Its web-based platform brings together a searchable collection of more than 214 million protein structures and tools for customizing proteins in 3D. Users can modify sequences at the amino acid level, including making mutations, cropping proteins, selecting domains, and inspecting their structures and functions.

After a design is complete, Gigabases’ algorithms encode it into a plasmid that can be ordered for research. The company offers mammalian, viral, and bacterial expression plasmids, which it describes as 100% sequence verified. Its catalog includes more than 2.5 billion ready-to-order expression plasmids, over 56,000 human proteins, and 36.8 million specialty enzymes, alongside resources related to more than 3,000 rare genetic diseases. Gigabases aims to streamline the path from protein discovery and design to plasmid ordering, supporting researchers seeking to explore new biological possibilities and advance their work.